GRAND RAPIDS, Mich. (WOOD) – Spectrum Health, Michigan State University and researchers from several hospitals along the Medical Mile teamed up to conduct a new study focusing on COVID-19 and the different reactions patients had to the disease.
Dr. Surender Rajasekaran is a medical research leader and pediatric intensivist at Helen DeVo’s Children’s Hospital. As a senior author of the study, Dr. Rajasekaran that understanding the patient’s response to the infection is the key to treating them.
He, co-author Jeremy Prokop and assistant professor at Michigan State University College of Human Medicine determined that COVID-19 patients fall into two main groups: one with a highly overactive immune system and the other with immune suppression. They examined 51 patients and took a closer look at each patient’s RNA in the blood. Dr. Rajasekaran says that RNA could be used to uncover a body’s response to disease and could change the approach to the medical treatment of a patient.